Infliximab versus azathioprine to prevent postoperative recurrence in Crohn's disease: are all controversial issues defined?

J Crohns Colitis. 2013 Dec;7(12):e698. doi: 10.1016/j.crohns.2013.07.007. Epub 2013 Aug 6.

Authors

Paulo Gustavo Kotze¹, Takayuki Yamamoto

Affiliation

¹ Colorectal Surgery Unit, Cajuru University Hospital, Catholic University of Parana, Curitiba, PR, Brazil. Electronic address: pgkotze@hotmail.com.

PMID: 23932785
DOI: 10.1016/j.crohns.2013.07.007

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Azathioprine / therapeutic use*
Crohn Disease / prevention & control*
Female
Humans
Immunosuppressive Agents / therapeutic use*
Infliximab
Male

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antibodies, Monoclonal
Immunosuppressive Agents
Infliximab
Azathioprine